Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Blood

• Publication date

  1985-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V66.6.1352.BLOODJOURNAL6661352PMID 3904870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

  1984cited by this paper
• ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA

  1984cited by this paper
• Randomized trial of splenectomy in Ph1‐positive chronic granulocytic leukaemia, including an analysis of prognostic features

  1983cited by this paper
• Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases.

  1983cited by this paper
• A multivariate analysis of prognostic factors in chronic myeloid leukemia.

  1982cited by this paper
• Successful allogeneic bone-marrow transplantation for patients in the accelerated phase of chronic granulocytic leukaemia.

  1982cited by this paper
• Prognostic features at diagnosis of chronic myelocytic leukemia

  1981cited by this paper
• Factors related to length of complete remission in adult acute leukemia

  1980cited by this paper
• METAMORPHOSIS OF CHRONIC GRANULOCYTIC LEUKAEMIA: DIAGNOSIS, CLASSIFICATION, AND MANAGEMENT

  1979cited by this paper
• Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

  1979cited by this paper
• Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas.

  1979cited by this paper
• Covariance analysis of censored survival data.

  1974cited by this paper
• Characteristics of the terminal phase of chronic granulocytic leukemia.

  1968cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course

  2022cites this paper
• Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology

  2021influential citation
• Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia

  2021cites this paper
• Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CML

  2021cites this paper
• The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)

  2020cites this paper
• The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

  2020cites this paper
• Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study.

  2020cites this paper
• The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China

  2018cites this paper
• Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents

  2017cites this paper
• Role of bone marrow biopsy in myeloproliferative neoplasm: study of 49 cases

  2017cites this paper
• Quimioterapia intensiva con 1-3 fármacos y soporte con células mielopoyéticas autologas extraídas de la sangre periférica: resultados preliminares

  2017cites this paper
• Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents

  2017cites this paper
• Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib

  2017cites this paper
• Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting

  2016cites this paper
• Prognostic Scoring in Patients of Chronic Myeloid Leukemia : Correlation between Sokal and Hasford Scoring Systems

  2016cites this paper
• Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

  2016cites this paper
• East Midlands Cancer Network Guidelines for the Investigation and Management of Patients with Chronic Myeloid Leukaemia (CML)

  2015cites this paper
• Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions.

  2015cites this paper
• Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?

  2015influential citation
• Managing children with chronic myeloid leukaemia (CML)

  2014cites this paper
• Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century

  2013cites this paper
• Prognostic factors and future direction for chronic myeloid leukemia

  2013cites this paper
• A Review of its Pharmacology and Therapeutic Use in the Treatment of Chronic Myelogenous Leukaemia

  2012cites this paper
• Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.

  2012cites this paper
• Sex and Gender Differences in Hematology

  2012cites this paper
• The isolation and characterisation of MHC-presented peptides from CML-derived cell-lines, with a focus on post-translational modification

  2011cites this paper
• Additional chromosome abnormalities in chronic myeloid leukemia

  2011cites this paper
• A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia.

  2010cites this paper
• Chronic myeloid leukemia: a historical perspective.

  2010cites this paper
• Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

  2010cites this paper
• Imatinib achieved complete cytogenetic response in a CML patient received 32-year indirubin and its derivative treatment.

  2010cites this paper
• Current status of imatinib as frontline therapy for chronic myeloid leukemia.

  2010cites this paper
• Prognostic factors in chronic myeloid leukaemia.

  2009cites this paper
• HDR - Eléments d'épidémiologie rénale : Impact du diabète sur la survie des patients insuffisants rénaux chroniques terminaux

  2009cites this paper
• An approach to the management of chronic myeloid leukemia in

  2008cites this paper
• Foie et syndromes myéloprolifératifs.

  2008cites this paper
• [Bone marrow transplantation as therapy in chronic myeloid leukemia].

  2008cites this paper
• Management of patients with resistant or refractory chronic myelogenous leukemia.

  2008cites this paper
• An approach to the management of chronic myeloid leukemia in British Columbia

  2008cites this paper
• Nilotinib therapy in chronic myelogenous leukemia.

  2007cites this paper
• Apports des méthodes récentes de modélisation de survie dans le contexte spécifique des patients dialysés

  2007cites this paper
• Analysis of Prognostic Factors Affecting Response to Treatment and Survival in Chronic Myeloid Leukemia Patients

  2007cites this paper
• Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).

  2006cites this paper
• Targeting ABL and SRC kinases in chronic myeloid leukemia: experience with dasatinib.

  2006cites this paper
• Leucémie myéloïde chronique

  2006cites this paper
• Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials.

  2006cites this paper
• Chronic myeloid leukemia: diagnosis and treatment.

  2006cites this paper
• Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia

  2006cites this paper
• CML Patients in Blast Crisis Have Breakpoints Localized to a Specific Region of the BCR

  2005cites this paper
• Gender aspects in chronic myeloid leukemia: long-term results from randomized studies

  2005cites this paper
• Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia

  2005cites this paper
• Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

  2004cites this paper
• Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants

  2004cites this paper
• Chronic Myelogenous Leukemia : A Concise Update

  2003cites this paper
• Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

  2003cites this paper
• Chronische myeloproliferative Erkrankungen

  2003cites this paper
• Prognosis of hematologic malignancies does not predict intensive care unit mortality

  2002influential citation
• [The liver and myeloproliferative syndromes].

  2002cites this paper
• Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.

  2001cites this paper
• The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.

  2001influential citation
• Bone M arrow F eatures I mprove P rognostic E fficiency i n Multivariate R isk C lassification o f C hronic-Phase P h 1 1 Chronic M yelogenous L eukemia: A M ulticenter T rial

  2001cites this paper
• CHRONIC MYELOGENOUS LEUKAEMIA

  2000cites this paper
• Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.

  2000cites this paper
• Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.

  2000cites this paper
• Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with α‐interferon

  2000cites this paper
• Stem Cell Transplantation for Chronic Myeloid Leukemia

  2000cites this paper
• Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.

  1999cites this paper
• Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia.

  1999cites this paper
• Leucémie myéloïde chronique

  1999cites this paper
• Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

  1998cites this paper
• Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.

  1998cites this paper
• A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

  1998cites this paper
• Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management.

  1998cites this paper
• Initial therapy for chronic myelogenous leukemia: playing the odds.

  1998cites this paper
• Related donor bone marrow transplantation for chronic myelogenous leukemia.

  1998cites this paper
• Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16‐year period

  1997cites this paper
• Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.

  1997cites this paper
• Use of Interferon-α in the Treatment of Chronic Myelogenous Leukemia

  1997cites this paper
• Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.

  1997cites this paper
• Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score

  1997cites this paper
• Chronic myelogenous leukemia: an update on the biological findings and therapeutic approaches.

  1996cites this paper
• Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome.

  1996cites this paper
• Chronic myeloid leukemia (CML): prognostic factors and survival analysis.

  1996cites this paper
• Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand.

  1996cites this paper
• [Busulfan versus busulfan-interferon as maintenance therapy in chronic myeloid leukemia].

  1996cites this paper
• Chronic myeloid leukemia treated with busulfan.

  1996cites this paper
• Analysis and validation of prognostic factors for CML. German CML Study Group.

  1996cites this paper
• Clinical and histological features retain their prognostic impact under interferon therapy of CML: A pilot study

  1995cites this paper
• Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.

  1995cites this paper
• A Review of its Pharmacology and Therapeutic Use in the Treatment of Chronic Myelogenous Leukaemia

  1995cites this paper
• Interferon-α-2a

  1995cites this paper
• Changing trends in the management of chronic granulocytic-leukemia.

  1995cites this paper
• Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia

  1995cites this paper
• Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries.

  1994cites this paper
• Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups.

  1994cites this paper
• The leukemias.

  1994cites this paper
• Management of chronic myeloid leukaemia.

  1994cites this paper
• Long‐term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group

  1994cites this paper
• The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase.

  1994cites this paper
• Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.

  1994cites this paper